Xu Diyong's most recent trade in Q32 Bio Inc. was a trade of 10,826 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 10,826 | 10,826 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 9,810 | 9,810 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 28 May 2026 | 1,250,000 | 3,502,987 | - | 8 | 10,000,000 | Common Stock |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 28 May 2026 | 625,000 | 625,000 | - | 8 | 5,000,000 | Common Stock |
| Q32 Bio Inc | Diyong Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2025 | 53,521 | 53,521 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Xu Diyong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Diyong Xu | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 12,767 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Diyong Xu | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) |